Alexion Pharmaceuticals Share Price Target Raised to $84.00 by Barclays ... Web Inquirer ... development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ... Alexion Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript |
